, respectively, of the Swedish Twin Registry; pairs for whom zygosity (i.e., the number of eggs that gave rise to the twins) could be determined were considered further. The association of cancer with combined genetic and nongenetic familial factors was tested by comparing all twin pairs (regardless of zygosity) in which at least one member of the pair had been diagnosed with cancer at one of several specific sites with pairs in which neither twin had that cancer. Heritable effects alone were tested by comparing monozygotic (one egg) and dizygotic (two eggs) twin pairs. Statistical methods used in quantitative genetics and standard methods for epidemiologic research were used in parallel to analyze the data. Results and Conclusions: In the 10 503 twin pairs from the old cohort, 3617 cases of malignant cancer were identified; 918 malignant cancers were identified in the 12 883 twin pairs from the young cohort. When cancer sites with a total number of at least 200 cases and at least one twin pair concordant (i.e., both twins affected) for the site were evaluated, namely, cancers of the stomach, colon and rectum, lung, female breast, and prostate, as well as total cancer, profound genetic and/or nongenetic familial effects were identified in twins from the old cohort. Similar findings were obtained for twins in the young cohort for cancers of the prostate and female breast, as well as for total cancer. Genetic and nongenetic familial effects were also identified in twins from both cohorts for in situ cancer of the cervix. The increase in
Familial clustering has been observed for cancer occurrence at many common sites, such as breast, colon, prostate, lung, and stomach (1, 2) . Most of the findings are based on data from ''cancer-prone'' families or interviews with subjects who have cancer. Although studies utilizing such data may be liable to bias, the observations are consistent enough to leave little doubt regarding the involvement of a heritable (i.e., genetic) component in the development of some cancers. Recent populationbased studies (3, 4) have arrived at similar conclusions. Genetic segregation analyses of breast, colon, and prostate cancers have suggested that the existence of rare autosomal dominant disease genes can explain the mode of inheritance in some families (2, 5) . The number of candidate genes being identified for colon, breast, and other cancers is growing.
Twins offer a natural study population for genetic epidemiology, because monozygotic twins are genetically identical, whereas dizygotic twins, like singletons, share half of their segregating genes. Thus, if heritable factors play a role in the origin of a disease, disease concordance should be greater in monozygotic twin pairs than in dizygotic twin pairs. Concordance in both monozygotic and dizygotic twin pairs of a similar magnitude suggests the contribution of a familial factor that may not necessarily involve genes (e.g., the impact of a shared environmental exposure). Despite the large amount of genetic information that exists in twin populations, such populations have been used only to a limited extent in cancer epidemiology.
The Swedish Twin Registry is a nationwide registry and is population based. In this study, we have linked the Swedish Twin Registry to the Swedish Cancer Registry to identify cases of cancer diagnosed during the period from 1959 through 1992 in twins born in the period from 1886 through 1958. The purpose of the study was to test the hypothesis, for each type of cancer with a sufficient number of cases in the Swedish Twin Registry, that heritable and nongenetic familial factors are of importance in determining cancer risk.
Methods
The Swedish Twin Registry consists of two cohorts for which data were collected in slightly different ways: the old cohort and the young cohort. The majority of the analyses in this article are based on the old cohort because of small numbers in the young cohort. The old cohort consists of all same-sex twin pairs born during the period from 1886 through 1925 with both individuals alive when the registry was established in 1959-1961, at which time the twins were asked to complete a questionnaire. The total number of same-sex twin pairs born during this period was 41 017, and the number of pairs in which both individuals were alive at the time of the questionnaire was 12 889. Questionnaire information that allowed zygosity to be assessed was available for 10 503 pairs (1649 monozygotic male pairs, 2007 monozygotic female pairs, 2983 dizygotic male pairs, and 3864 dizygotic female pairs). Zygosity assessment was based on the following question: ''Were you as children as alike as two peas in a pod?'' When both twins answered affirmatively, they were defined as monozygotic. Less than 5% of the twins disagreed in their answers, and those were excluded. When monozygosity assessed through the questionnaire was evaluated serologically, the sensitivity was estimated at 99% and the specificity at 92% (6) .
The young cohort included all twins born during the period from 1926 through 1958 who were alive and living in Sweden in 1970. In 1972, a questionnaire was sent to all same-sex pairs in which both individuals were alive. Responses that allowed a determination of zygosity were received from 12 883 pairs (2293 monozygotic male pairs, 2736 monozygotic female pairs, 3690 dizygotic male pairs, and 4164 dizygotic female pairs), and the information from these twins is used in the present analyses.
Mortality in the two twin cohorts was determined by linkage to the Mortality Registry of Statistics, Sweden. The twin cohorts were also matched with the national Swedish Cancer Registry maintained by the National Board of Health and Welfare. At the time of the record linkage, the Swedish Cancer Registry contained all cases of cancer that were diagnosed during the period from 1959 through 1992. The Swedish Cancer Registry classifies cases of cancer according to the seventh revision of the International Classification of Diseases (7).
The following two research questions were addressed: 1) Are there familial factors for cancers? 2) Do the familial factors reflect heritable factors, or are they the result of family members sharing environmental factors (such as lifestyle) or both? The presence of genetic and nongenetic familial effects was tested by a comparison of all twin pairs, regardless of zygosity, in which at least one of the members had been diagnosed with a particular cancer to pairs in which neither of the twins had that cancer. Heritable effects were tested by analytic techniques that compare monozygotic and dizygotic twin pairs.
The research questions were evaluated by use of two analytic approaches. In the first approach, we estimated the relative risk (RR) of cancer for twins whose partner had been diagnosed with a given cancer compared with twins whose partner had not been so diagnosed. The RR for all twin pairs together reflects the combined familial effect, whereas a comparison between monozygotic and dizygotic twin pairs may separate a heritable genetic component. RRs for all twins and for monozygotic and dizygotic twin pairs separately were estimated by means of the odds ratio obtained from the disease concordant pairs, the diseasefree concordant pairs, and the two types of discordant pairs (8) . For the comparison between monozygotic and dizygotic twins, a recently proposed method was used (9) . Briefly, a proportional hazards model was applied to those twins whose partner was diagnosed with a given cancer for whom follow-up information from the time of the partner's diagnosis was available. The model included age at onset as a covariate. The estimated relative hazard, or RR, indicates whether a cancer in the twin partner has a stronger effect on cancer incidence in a monozygotic twin than in a dizygotic twin.
In the second approach, which used quantitative genetic techniques, the relative importance of heritable factors and environmental factors for liability to disease was estimated. Concordance rates, a widely used indicator of twin similarity, were computed to facilitate comparisons with other studies and to inform the choice of parameters to be estimated in subsequent quantitative genetic analyses. The probandwise concordance rate was computed as the probability that a twin is affected given that his/her co-twin is affected (10) . The importance of heritable effects is indicated by greater within-pair similarity among monozygotic pairs than among dizygotic pairs. Shared environmental effects reflect twin similarity that is not explained by heritable genetic effects. As noted above, familial effects include contributions from both heritable factors and shared environmental factors. Nonshared environmental effects are evidenced by within-pair differences. When calculating the proportion of variance explained, two-by-two contingency tables of disease status in twin pairs (twin A versus twin B) separately by zygosity status were entered into a structural model-fitting program (11) to provide estimates of the relative importance of genetic and shared environmental sources of variance for liability to disease. These two-bytwo tables provide information comparable to concordances. Standard quantitative genetic methods as described by Neale and Cardon (12) were used to estimate the following three parameters: 1) heritability (h 2 ), i.e., the proportion of total variance due to genetic variance; 2) shared environmental effects (c 2 ); and 3) nonshared environmental effects (e 2 ).
Results
In the old cohort of 10 503 twin pairs, a total of 3617 cases of malignant cancer were identified through record linkage to the Swedish Cancer Registry. The total number of malignant cancer cases in the young cohort of 12 883 twin pairs was 918. Results for individual cancer sites that had a total number of at least 200 cases and at least one twin pair concordant for that site are presented (Tables 1-6 ). According to these criteria, urinary bladder cancers would have been included; however, the numbers were too sparse to allow for estimation of the variance components. Because of small numbers in the young cohort, results for this cohort are given only for the most common cancers. The results for all malignant cancers are reported in Table 7 along with the numbers of twin pairs according to sex and zygosity.
Both analyses of liability to disease and RR estimates provide evidence for a familial effect in stomach cancer in males as well as in females ( Table 1 ). The proportion of variance explained by shared environmental effects and heritable effects together (familiality) is about 30%, and the RR of stomach cancer for those twins whose partner has been diagnosed with stomach cancer is about 5. This finding holds true for both sexes. For each sex, however, there is only one concordant monozygotic pair, which precludes delineation of a heritable effect.
For colon and rectum cancer, there is again evidence for a familial effect by both analytic approaches and for both sexes (Table 2 ). For males, the proportion of variance explained by familiality is estimated at 43%, and the RR for monozygotic and dizygotic pairs together is 4.9 (95% confidence interval [CI] ‫ס‬ 2.5-9.6), whereas the corresponding numbers for females are 27% and 3.9 (95% CI ‫ס‬ 2.0-7.3). For males, there is also evidence of a separate heritable effect, as indicated by the proportion of variance explained by genetic factors as well as by the RR comparing monozygotic and dizygotic pairs. For females, there are only two concordant monozygotic twin pairs.
The lung cancer data also suggest a familial effect for males (Table 3 ). The proportion of variance explained by familial factors is 30%, and the RR for both zygosity types together is 5.5 (95% CI ‫ס‬ 1.9-15.6). Although small numbers make the estimates uncertain, there is no indication of the importance of genetic effects. For females, there are no concordant pairs regardless of zygosity.
For breast cancer, data from the old and the young cohorts are ARTICLES reported (Table 4) . For both cohorts, both the variance and the RR estimates indicate a familial effect. A substantial genetic effect is also evident for both cohorts and with both analytic approaches.
For cervical cancer, the number of malignant cases is too small to allow for an analysis; thus, Table 5 is restricted to in situ cases. For the old cohort, the analysis suggests a strong familial effect explaining 46% of the variance and an RR of 8.2 (95% CI ‫ס‬ 2.5-27.3). However, there are no concordant dizygotic pairs. The results are similar for the young cohort, although the total RR, estimated at 3.3 (95% CI ‫ס‬ 2.4-4.6), is somewhat lower. In this cohort, a moderate heritable effect explaining 39% of the variance in liability is indicated by the data; the RR comparing monozygotic and dizygotic pairs is estimated at 2.0 (95% CI ‫ס‬ 1.1-3.5).
Prostate cancer displays a clear familial effect that is almost entirely accounted for by heritable effects (Table 6 ). For the old cohort, all of the 36% variance explained is attributable to heritable factors, and the RR between monozygotic and dizygotic pairs is estimated at 6.3 (95% CI ‫ס‬ 2.5-16.0). Despite small numbers, a similar tendency also appears in the young cohort.
All malignant cancers together, regardless of site, show a clear but weak familial effect for both sexes in the old cohort (Table 7) . Familial effects explain 15% and 17% of the variance for males and females, respectively, whereas the corresponding RRs are 1.3 (95% CI ‫ס‬ 1.1-1.6) and 1.6 (95% CI ‫ס‬ 1.3-1.8). The data suggest that almost all of this familial effect can be ascribed to the heritable component. For the young cohort as well, all familial effects are due to heritable factors, and here the heritable influence is even more pronounced.
Discussion
The major findings of this study were the profound familial effects for all cancer sites presented as well as for total cancer. A heritable component could be distinguished for colon and rectum cancer in males, for female breast cancer, for in situ cervical cancer, for prostate cancer, and for total cancer. For female breast cancer and total cancer, the findings were more pronounced in the young cohort. Family studies on cancers such as those of the colon and breast have identified hereditary forms that can explain an estimated 10% of the total cancers at these sites (1, 2) .
Despite the fact that all Swedish twins born in the period from 1886 through 1958 were followed for cancer during the entire period covered by the Swedish Cancer Registry (1959 through 1992), one major limitation of this study is the small number of concordant cancer cases at specific sites. Because the analyses of genetic effects are based on comparisons between monozygotic and dizygotic twin pairs, difficulties with small numbers become even more pronounced when the data must be subdivided and the power to find genetic effects is low. The other consequence of small numbers is that no conclusions about the absence of familial or genetic effects can be drawn from the absence of observed effects for most cancer sites. The reason is simply that the power of resolution becomes so low that effects may easily go undetected.
There is one inherent difficulty in this kind of study that originates from the fact that the Swedish Cancer Registry contains only cancers diagnosed from 1959 and onward. Thus, about 70% of all twin pairs in the old cohort are lost to the analysis because of death or no response for one or both twins in a pair. Presumably, a majority of the losses were the result of perinatal deaths; but, of course, some were caused by cancer, and those cancers occurred at a relatively young age. If genetic factors have a stronger effect at younger ages, this loss of cancer cases may lead to an underestimation of genetic effects.
Breast and prostate cancers have been studied recently in the Swedish Twin Registry (13, 14) . In the present study, however, the follow-up time was through 1992, whereas the previous breast cancer study included cancer only up to 1982 and the prostate cancer study included it only up to 1989. The present study also included the young cohort whenever numbers so allowed. For female breast cancer, a comparison between the two cohorts indicated a more pronounced effect in the young cohort. This difference may have been exaggerated by the loss of some cases in the old cohort before 1959. The difference might be due entirely to a cohort effect, but it might also reflect a genetic effect that is stronger in young women. Prostate cancer affects mainly older men, and the young cohort provided no useful information. The findings are similar to those in the previous report (14) , with a pronounced genetic effect. The strikingly high RR indicates a nonadditive heritable effect.
Stomach cancer and colon and rectum cancer were previously included in a follow-up of the Swedish Twin Registry through 1973 (15) , but nothing has been published since then. Family and genetic segregation studies, however, do suggest that there is a genetic component. At least for colon cancer, familial studies have shown that genetic components may play a role, and there is now a growing number of candidate genes for cancer at this site (4). The present findings for the men in the old cohort support these findings and suggest that genetic effects may play a large role.
Even though lung cancer is a common cancer in males in Sweden, the number of concordant twin pairs was low, and there were no such pairs for females. For males, the probandwise concordance rates were as low as 0.04 and 0.08 for monozygotic and dizygotic twins, respectively. Nevertheless, there was a clear familial effect, although any heritable component could not be delineated. This finding is similar to results reported from the U.S. National Academy of Science Twin Registry (16) . That study compared observed and expected lung cancer concordant pairs for monozygotic and dizygotic twins. For both twin types, there was an excess of observed relative to expected concordant pairs; however, this excess was of the same magnitude for the two twin types. This result suggests an effect of shared environment or lifestyle but no heritable effect, just like the findings in the present study. Given the importance of smoking for lung cancer risk, smoking habits are most likely an important source of familial effects for lung cancer.
The analyses on total cancer are based on concordance for total cancer and not on concordance for specific cancer sites. Particularly for the old cohort, the numbers are sufficiently large to allow for robust estimation. The findings are quite clear in that a stable but weak familial effect is observed for both males and females and in that a genetic component can also be distinguished. Analysis of total cancer in U.S. male twins gave similar results (17) . Findings for the young cohort presented here are similar, except that the effects are somewhat stronger than those found for the old cohort and the U.S. twin study population. This result probably indicates that the effects are stronger for the younger age groups. Although very modest, these estimates appear to indicate that genetic effects influence cancer risk in general. Thus, a general genetic mechanism for susceptibility to cancer may exist, regardless of site. Analyses presented here indicate that genetic effects can explain more than 10% of the studied cancer forms. Therefore, we should expect to find more genes of importance for cancer-each having a small effect, however, and possibly mediated through environmental factors.
Twin studies generally use statistical techniques from quantitative genetics that often involve calculation of concordance rates and estimation of variance of liability for disease. On the other hand, epidemiologic research is usually based on incidence rates and incidence rate ratios, often referred to as relative risks. In this study, both of these approaches were used in parallel. Without exception, the conclusions were the same, regardless of which approach was used. However, it is not clear that such a result would always be the case, and it would be useful for more analyses to compare these two approaches. In a letter to the editor (9) following the recent publication (14) of a study based on the Swedish Twin Registry, it was claimed that traditional quantitative genetic methods may not be informative enough because they do not take into account time and because they prohibit control for confounding. However, in the RR estimates comparing monozygotic and dizygotic twins, the proportional hazards technique suggested by Gann (9) was used. Thus, we are encouraged by the consistency in the findings from the two analytic techniques.
